Five connected areas. One woman. One coordinated plan.
StrongHer Care is designed for the clinical reality of midlife: symptoms overlap, risks change, and the right answer is rarely found inside one narrow specialty lane.
M01
Menopause & Midlife
Care begins with the woman’s goals, symptoms, health history, risk profile, and preferences, not with a single treatment philosophy.
Perimenopause and menopause symptom assessment
Hormonal and nonhormonal treatment options
Premature ovarian insufficiency, early menopause, and surgical menopause
Sleep, mood, vasomotor, cognitive, and quality-of-life concerns
Coordination of cardiovascular, metabolic, and preventive care
P02
Pelvic, Vulvovaginal & Urinary Health
Midlife symptoms may cross traditional specialty boundaries. The pathway keeps the pelvic floor, urinary tract, vulva, vagina, and sexual function in the same clinical picture.
Genitourinary syndrome of menopause (GSM)
Recurrent urinary tract infections
Vulvar and vaginal symptoms
Painful intercourse and pelvic pain
Urinary symptoms, prolapse, and pelvic-floor dysfunction
Pelvic-floor physical therapy and specialty referral when appropriate
S03
Sexual Health
Sexual health is addressed as health care, without judgment and without reducing every concern to hormones.
Desire, arousal, orgasm, and pain concerns
Medication and medical contributors
Pelvic-floor and genitourinary contributors
Evidence-based pharmacologic options when appropriate
Referral pathways for counseling, therapy, and additional specialty care
C04
Cancer-Survivorship Support
Women affected by cancer deserve symptom relief and honest risk discussions, even when systemic hormone therapy is not an option.
Nonhormonal management of menopause symptoms
GSM, urinary, and sexual-health care
Bone-loss risk related to ovarian suppression or endocrine therapy
Individualized shared decision-making with oncology when needed
Clear distinction between survivorship symptom care and oncologic surveillance
B05
Bone Health
Bone health is not a separate chapter of midlife care. It is part of the same hormonal, medical, functional, and survivorship story.
DXA interpretation and fracture-risk assessment
Evaluation for secondary causes when indicated
Nutrition, vitamin D, exercise, strength, balance, and fall-risk counseling
Oral, injectable, and infusion treatment selection when appropriate
Coordinated zoledronic acid and denosumab pathways
Longitudinal monitoring and safe transition planning
What integrated does not mean: one clinician doing everything. It means one accountable pathway that knows when to treat, when to coordinate, and when to bring in another specialist.
